NUP214 抗体 (AA 28-238) (HRP)
-
- 抗原 See all NUP214 抗体
- NUP214 (Nucleoporin 214kDa (NUP214))
-
抗原表位
- AA 28-238
-
适用
- 人
-
宿主
- 兔
-
克隆类型
- 多克隆
-
标记
- This NUP214 antibody is conjugated to HRP
-
应用范围
- ELISA
- 交叉反应
- 人
- 纯化方法
- >95%, Protein G purified
- 免疫原
- Recombinant Human Nuclear pore membrane glycoprotein 210 protein (28-238AA)
- 亚型
- IgG
- Top Product
- Discover our top product NUP214 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - 储存液
- ProClin
- 注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 储存条件
- -20 °C,-80 °C
- 储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- 抗原
- NUP214 (Nucleoporin 214kDa (NUP214))
- 别名
- NUP21 (NUP214 产品)
- 别名
- CAN antibody, CAN/Nup214 antibody, CG3820 antibody, DCAN antibody, DNup214 antibody, Dmel\\CG3820 antibody, Nup 214 antibody, dCAN antibody, l(2)10444 antibody, nup214 antibody, NUP214 antibody, RGD1304977 antibody, BC039282 antibody, D2H9S46E antibody, CAIN antibody, D9S46E antibody, N214 antibody, p250 antibody, Nucleoporin 214kD antibody, nucleoporin 214kDa antibody, nucleoporin 214 antibody, Nup214 antibody, NUP214 antibody
- 背景
-
Background: Nucleoporin essential for nuclear pore assembly and fusion, nuclear pore spacing, as well as structural integrity.
Aliases: FLJ22389 antibody, GP 210 antibody, KIAA0906 antibody, Nuclear envelope pore membrane protein POM 210 antibody, Nuclear pore membrane glycoprotein 210 antibody, Nuclear pore protein gp210 antibody, Nucleoporin 210 antibody, Nucleoporin 210 kDa antibody, Nucleoporin Nup210 antibody, Nucleoporin210 antibody, NUP 210 antibody, Nup210 antibody, PO210_HUMAN antibody, POM 210 antibody, POM210 antibody, Pore membrane protein of 210 kDa antibody
- UniProt
- Q8TEM1
- 途径
- Protein targeting to Nucleus, SARS-CoV-2 Protein Interactome, The Global Phosphorylation Landscape of SARS-CoV-2 Infection
-